>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

OSTK +13%, ACXM +6.9%, BDN +5%, AAPL +4.7%, AMD +4.6%, AKER +4%, VNTV +3.6%,OKE +3.2%, FBHS +3.1%, (also CFO Lee Wyatt will retire)
ALGN +3.1%, (also files patent infringement lawsuit against ClearCorrect and Your Smile Direct in United Kingdom), TUP +2.7%
CARB +2.3%, (Carbonite acquired Double-Take Software for $65.25 mln and reports prelim Q4 results, issues FY17 guidance with Double-Take Software impact)
BAX +2.3%, AVY +2.1%, X +1.6%, EQR +1.3%, USG +1.3%, ALGT +1.2%, MTSI +0.9%,ANTM +0.6%

M&A news:

OKS +28.7% (ONEOK (OKE) to acquire all of the outstanding common units of ONEOK Partners it does not already own for $9.3 bln in common stock)
CERU +11.1% (announces that its Board is conducting a comprehensive review of strategic alternatives)
OPHT +1.9% (initiates plan to review its strategic alternatives in order to maximize shareholder value)

Select Apple suppliers/related names showing strength:

CRUS +2.8%, SWKS +2.1%, AVGO +2.1%, MU +1%, QRVO +0.5%, QCOM +0.4%

Other news:

GALT +20.2% (says has generated sufficient financing to cover currently planned expenditures through 2017, remains on track to present top line data from its NASH-CX Phase 2 clinical trial by early December), VCEL +17.3% (announces the first implant of MACI in the US)
DRYS +12.7% (DryShips confirms will release its results for the fourth quarter on February 7 after the close)
XOMA +8.9% (established proof-of-concept for its product candidate 358 in congenital hyperinsulinism and hypoglycemia post-bariatric surgery)
NSTG +8.8% (announces that Humana has issued a positive coverage decision for the Prosigna Breast Cancer Gene Signature Assay)
SDRL +7% (rebounding following yesterday's declines)
OPXA +3.2% (further reduces workforce, terminates the employment Chief Scientific Officer)
TEVA +2.3% (rebounding following yesterday's declines)
MFIN +2.2% (Medallion Fincl provides long-term strategic update in ongoing transition away from medallion lending; to restructure Freshstart Venture Capital debentures, reducing Medallion exposure )
PMD +2% (following late move higher after co issued press release claiming no ownership interest in Psychemedics Brasil-- still closed significantly lower)
FB +1.2% (Facebook working to develop an app for TV set-top boxes, according to the WSJ )

Analyst comments: